Klaus Godl

An efficient proteomics method to identify the cellular targets of protein kinase inhibitors

Klaus Godl, Josef Wissing, Alexander Kurtenbach et al. · Proceedings of the National Academy of Sciences · 2003 · 333 citations · Full text

Cellular Targets of Gefitinib

Dirk Brehmer, Zoltán Greff, Klaus Godl et al. · Cancer Research · 2005 · 239 citations · Full text

The N Terminus of the MUC2 Mucin Forms Trimers That Are Held Together within a Trypsin-resistant Core Fragment

Klaus Godl, Malin Johansson, Martin E. Lidell et al. · Journal of Biological Chemistry · 2002 · 209 citations · Full text

Protein Secretion, Glycobiology, Molecular Biology +16

Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer

Martin Klammer, Marc Kaminski, Alexandra Zedler et al. · Molecular & Cellular Proteomics · 2012 · 119 citations · Full text

Proteome-wide Identification of Cellular Targets Affected by Bisindolylmaleimide-type Protein Kinase C Inhibitors

Dirk Brehmer, Klaus Godl, Birgit Zech et al. · Molecular & Cellular Proteomics · 2004 · 106 citations · Full text

Drug Target, Cdk2 Crystal Structure, Cellular Targets Affected +19